This is the ideal opportunity to meet with some of the biggest names in hepatology in a face to face interactive setting!
Invited experts will provide answers to challenging questions from Thursday 11 to Sunday 14 April during 36 informal workshops.
Gain time with a fast-track ticket!
Get your ticket now via the registration platform.
If you didn’t book a fast track ticket during your online registration, you can get one on-site at the registration desk located in Foyer D (limited number of tickets). Please note that your fast track ticket won’t be accepted after the session has started.
Didn’t manage to get a fast track ticket before the session? You still have the chance to get in on a first come first serve basis up to five minutes after the beginning of the session.
Programme
Room: Stolz 1
| 08:30 – 09:20 | Is screening for HCC recurrence cost-effective after liver transplantation. Do we need to perform HCC screening after liver transplantation? | Chairs: Christophe Duvoux, Christian Toso |
| 09:30 – 10:20 | Exercise or diet – which is best for NAFLD | Chairs: Mike Trenell, Shira Zelber-Sagi , Israel |
| 10:30 – 11:20 | Preventing long-term complications in OLT | Chairs: Marina Berenguer Haym, Puneeta Tandon |
| 12:00 – 12:50 | How to decide for resection versus other therapies in HCC? | Chairs: Alejandro Forner,Vincenzo Mazzaferro |
| 16:00 – 16:50 | Local therapies in HCC | Chair: Peter Galle |
| 17:00 – 17:50 | Renal dysfunction in the cirrhotic patient | Chairs: Claire Francoz, Salvatore Piano |
Room: Stolz 2
| 08:30 – 09:20 | Wilson’s disease | Chair: Peter Ferenci |
| 09:30 – 10:20 | What are the remaining difficult to treat patients and how to manage them? | Chairs: Alessandra Mangia, Stefan Zeuzem |
| 10:30 – 11:20 | JHEP reports – meet the new editorial team | Chairs: Jessica Zucman-Rossi, Sven Francque |
| 12:00 – 12:50 | Animal models of liver disease | Chair: Jordi Gracia-Sancho |
| 16:00 – 16:50 | Artificial intelligence in hepatology – where are the applications? | Chair: Andre Esteva |
| 17:00 – 17:50 | How to manage the chronic hepatitis Delta? | Chairs: Maria Buti, Mario Rizzetto |
Room: Stolz 1
| 11:30 – 12:20 | Multidisciplinary approach for management of alcohol related liver disease | Chairs: Giovanni Addolorato, Aleksander Krag |
| 14:00 – 14:50 | Hepatic encephalopathy | Chairs: Jasmohan S Bajaj, Sara Montagnese |
| 16:00 – 16:50 | Cell therapy for liver disease | Chairs: Stuart Forbes, Michael Ott |
| 17:00 – 17:50 | Targeted therapies in genetic errors of metabolism | Chairs: Elmar Aigner, Paul Gissen |
Room: Stolz 2
| 11:30 – 12:20 | Management of coagulation changes in patients with liver disease undergoing an invasive procedures | Chairs: Erica Villa, Ton Lisman |
| 14:00 – 14:50 | Management of immunosuppression in AIH | Chairs: Ansgar Lohse, Giorgina Mieli-Vergani |
| 16:00 – 16:50 | Endoscopic versus surgical bariatric approaches as interventions for NAFLD | Chairs: Jude A. Oben, Lars Aabakken |
| 17:00 – 17:50 | Management of symptoms of PBC | Chairs: Annarosa Floreani, Albert Pares |
Room: Stolz 1
| 08:00 – 08:50 | Kidney failure after liver transplantation | Chairs: Patrizia Burra, Didier Samuel |
| 09:00 – 09:50 | Hepatitis B: When to stop NA therapy? | Chairs: Maurizia Brunetto, George Papatheodoridis |
| 12:30 – 13:20 | Assessing patients with NASH for transplantation | Chair: Frank Tacke |
| 13:30 – 14:20 | Bile duct strictures in PSC: observation or intervention? | Chairs: Annika M. Bergquist, Stephen Pereira |
| 14:30 – 15:20 | Clinical management of polycystic liver disease | Chairs: Joost Ph Drenth, Mario Strazzabosco |
Room: Stolz 2
| 08:00 – 08:50 | When to use TIPS in cirrhosis | Chairs: Christophe Bureau, Guadalupe Garcia-Tsao |
| 09:00 – 09:50 | New MRI contrast agents in the diagnosis and staging of liver tumours | Chairs: Carmen Ayuso, Fabio Piscaglia |
| 12:30 – 13:20 | Hepatitis B: Which new drugs are in development and how do they work? | Chairs: Ulrike Protzer, Fabien Zoulim |
| 13:30 – 14:20 | Gut microbiota and liver disease – where are the therapeutic opportunities? | Chair: David Adams |
| 14:30 – 15:20 | Weaning of immunosuppression after liver transplantation | Chair: Alberto Sanchez-Fueyo |
Room: Stolz 1
| 08:30 – 09:20 | Portosinusoidal vascular disease: what is there behind this new name? | Chairs: Juan-Carlos Garcia-Pagan, Laure Elkrief |
| 09:30 – 10:20 | Management of non response to therapy in PBC patients | Chairs: Olivier Chazouillères, Michael Trauner |
| 10:30 – 11:20 | Acute liver failure | Chairs: Fin Stoltze Larsen, Julia Wendon |
Room: Stolz 2
| 08:30 – 09:20 | Haemochromatosis | Chair: Heinz Zoller |
| 09:30 – 10:20 | Management of gastric varices | Chairs: Arnulf Ferlitsch, Virginia Hernandez-Gea |
| 10:30 – 11:20 | Pharmacotherapy in NAFLD – which endpoints to use in everyday practice? | Chairs: Sven Francque, Vlad Ratziu |